Definium Therapeutics
A Senior Director, Product Communications at Definium Therapeutics leads strategic communications for the company’s late-stage pipeline, including Phase 3 data readouts, regulatory filings, and future launch readiness. This role shapes the external and internal narrative around Definium’s scientific rigor and innovation, ensuring consistent, credible, and high-impact messaging across multiple channels.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
26% above the average for this role
Director, Communications (APAC)
Open Text Web Solutions Usergroup eV
Public Relations Lead, Product & Tech
Waymo
Sr Mgr External Communications
Republic Services
Senior Principal Communications Representative
Northrop Grumman
Senior Associate, Public Relations & Communications
Progyny, Inc
Communications Director, Office of the CEO
Alteryx